Correction: Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1

Correction to: Blood Cancer Journal 10.1038/s41408-023-00826-6, published online 13 April 2023

Following the publication of this article an error was noted in Fig. 1. In the original publication, in panel A of Fig. 1, an incorrect Western blot for PBX3 was inadvertently used during the preparation of the figure.

The correct Western blot for PBX3 in panel A of Fig. 1 is presented below. The correction of this figure does not affect the reported results or the conclusions of the article.

The original article has been corrected.